): The specialized research of the SPORE involves translational research integrating laboratory and clinical studies, interdisciplinary research, inter-project collaboration, and use of specialized resources like the Pathology and Tissue Resource by the projects. These endeavors require biostatistical experience, a facile means of communication, and the ability to share, analyze, and rigorously audit data, particularly clinical data. The Informatics Core was thus devised as a central and essential specialized resource that would be used by all the established and developmental projects of the SPORE as well as in its career development program to meet these needs. The collaborative interaction of UTSW and UTMDA in creating the University of Texas Lung Cancer SPORE makes the Informatics Core of even greater importance to facilitate inter-institutional integration. The purposes of the Informatics Core are as follows: 1) To provide the statistical analysis required to achieve the specific aims of each project. 2) To assist in the design and analysis of new research arising from individual projects. 3) To facilitate electronic communication including the sharing of data and results between projects, cores and investigators and thus promote interdisciplinary, inter-project, and inter-institutional integration and collaboration. 4) To supervise and coordinate the collection, entry, and maintenance of data required for each project. 5) To provide for rigorous data management, quality assurance, auditing procedures, and confidentiality of clinical trials data. 6) To coordinate the data acquisition and biostatistical analysis and audit planning for the Internal Data Monitoring Committee. 7) To provide the above informatics support for the Developmental Projects and Career Development Trainees.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA070907-05S9
Application #
6662776
Study Section
Project Start
2000-09-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Parra, Edwin R; Villalobos, Pamela; Mino, Barbara et al. (2018) Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma. Appl Immunohistochem Mol Morphol 26:83-93
Yamauchi, Mitsuo; Barker, Thomas H; Gibbons, Don L et al. (2018) The fibrotic tumor stroma. J Clin Invest 128:16-25
Ma, Junsheng; Hobbs, Brian P; Stingo, Francesco C (2018) Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. Stat Methods Med Res 27:2093-2113
Yi, Faliu; Yang, Lin; Wang, Shidan et al. (2018) Microvessel prediction in H&E Stained Pathology Images using fully convolutional neural networks. BMC Bioinformatics 19:64
Song, Kai; Bi, Jia-Hao; Qiu, Zhe-Wei et al. (2018) A quantitative method for assessing smoke associated molecular damage in lung cancers. Transl Lung Cancer Res 7:439-449
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
He, Min; Liu, Shanshan; Gallolu Kankanamalage, Sachith et al. (2018) The Epithelial Sodium Channel (?ENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors. Transl Oncol 11:292-299
Parra, Edwin R; Villalobos, Pamela; Behrens, Carmen et al. (2018) Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 6:48
Guo, Hou-Fu; Tsai, Chi-Lin; Terajima, Masahiko et al. (2018) Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding. Nat Commun 9:512
Meraz, Ismail M; Majidi, Mourad; Cao, Xiaobo et al. (2018) TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. Cancer Immunol Res 6:163-177

Showing the most recent 10 out of 1059 publications